Single-tube, coupled transcription/translation systems for eukaryotic in vitro translations
$211.86 - $793.95
U.S. Patents 5,324,637 and 5,492,817; Australian Patent 660329.U.S. Patents 5,641,641; 5,650,289; and 5,814,471; Australian Patent 649289.Australian Patents 616881 and 641261 and other pending and issued patents, which claim vectors encoding a portion of human placental ribonuclease inhibitor, are exclusively licensed to Promega Corporation.The method of recombinant expression of Coleoptera luciferase is covered by U.S. Patents 5,583,024; 5,674,713; and 5,700,673. A license (from Promega for research reagent products and from The Regents of the University of California for all other fields) is needed for any commercial sale of nucleic acid contained within or derived from this product.